Skip to main content
SpringerLink
Log in

Blasenkrebs: Plädoyer für Organschonung

  • Literatur kompakt_Urogenitale Tumoren
  • Published:
Im Focus Onkologie Aims and scope

Es gibt immer mehr Hinweise, dass organschonendes Vorgehen beim muskelinvasiven Blasenkarzinom eine Alternative zur Zystektomie ist. Die Langzeitergebnisse haben US-Ärzte anhand der Daten von sechs Studien analysiert.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Mak RH et al. Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233. J Clin Oncol. 2014;32(34): 3801-9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Peter Leiner

Authors
  1. Peter Leiner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Leiner, P. Blasenkrebs: Plädoyer für Organschonung. Im Focus Onkologie 17, 31 (2014). https://doi.org/10.1007/s15015-014-1497-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15015-014-1497-z

Search

Navigation